Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism EBP inhibitors(EBP cholestenol delta-isomerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis, Liver | Preclinical | CN | 13 Apr 2023 |